Amazon shares drop 3.83% as AWS launches Neuron 2.33 for Trainium chips

Amazon.com Inc. saw its stock fall 3.83% to $252.31 after announcing the launch of AWS Neuron 2.33, software designed to simplify the use of its Trainium AI accelerators. The company reported second‑quarter AWS revenue up 37% to $42.2 billion. Early adoption includes more than 30 customers, according to Reuters. The share price is trading just above the Gurufocus value estimate.

The decline shows investors reacting to the product launch and the latest revenue figures, pulling the stock below its recent high. The price move may affect short‑term trading strategies and valuation models that reference the GF Value estimate.

  • 1Amazon shares fell 3.83% to $252.31 on Thursday.
  • 2AWS Neuron 2.33 software was launched to ease adoption of Trainium AI chips.
  • 3AWS Q2 revenue rose 37% to $42.2 billion.
  • 4More than 30 early customers are using the new software, per Reuters.
  • 5The stock is trading near the GF Value estimate of $252.04.

Sources